PARP Inhibitors & Women with Ovarian Cancer

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
259 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 5, 2010

Prof. A. Hilary Calvert, Clinical Director of Northern Institute for Cancer Research received the 2010 ESMO Lifetime Award for Carboplatin Work. Here he discusses PARP inhibitors and their importance for women with ovarian cancer.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more